COPD case finding in the community

In Australia, there are over 400,000 people that have COPD but don’t have a confirmed diagnosis. If these people are identified early and managed well they can have better health outcomes.

Lung Foundation Australia supports targeted COPD case-finding in the community using COPD screening devices. The main aim of targeted COPD case-finding with a COPD screening device is to identify those at risk of COPD and avoid unnecessary spirometry in those with normal lung function.

Piko6 Hand Held Device COPD6 Hand Held Device
PiKo-6 Hand Held Device COPD-6 Hand Held Device

 

Where can I obtain a COPD screening device?

The PiKo-6 screening devices can be purchased from Lung Foundation Australia.

PiKo Products

To purchase any Piko products from our online shop, click on the icon below.

Order Form nSpire Products PiKo (389 KB)

 

The COPD-6 can be purchased by clicking here. 

 

COPD Screening Resources

To support targeted COPD case-finding using COPD screening devices, the Lung Foundation has developed the following:

  • Position paper including screening algorithm
  • COPD screening results form for General Practice, Pharmacy and Community Settings
  • Training Video on the steps in undertaking a COPD Risk assessment and screening activity with a COPD screening device (approximately 15 minutes)
  • Instruction sheets for the PiKo-6 and COPD-6
  • Case studies

 

Position Paper

Position Paper (285 KB) Screening algorithm (46 KB)

 

Results Forms

Community Settings (850 KB) Pharmacy (850 KB) Results Form - General Practice (469 KB)

 

Versions of the results form in rich text format (rtf) for download to medical software

 

Medical Director:

  1. Instructions for importing to Medical Director (225 KB)

  2. Once you have downloaded the instructions, save the Rich Text Format (rtf) document to your computer.  Please note: If you download the document without selecting ‘save as’ you may lose formatting of the file.
  3. General Practice results form for Medical Director (32 KB)

Best Practice:

  1. Instructions for importing to Best Practice (192 KB)

  2. Once you have downloaded the instructions, save the Rich Text Format (rtf) document to your computer. Please note: If you download the document without selecting ‘save as’ you may lose formatting of the file
  3. General Practice results from for Best Practice (31 KB)

 

This contraindications sheet may be printed and used in combination with this activity.

COPD Screening Contraindications (181 KB)

 

Training Video

This short training video (approximately 15 minutes) is available free of charge.

The video shows how to undertake the five steps in a COPD risk assessment and case finding activity. Click the image to activate the video.

COPD Screen Device

If you cannot see the video it may be because:

  • it is behind your current browser window
  • you may need to download the free Flash Player software (Download)

COPD Risk Assessment and Screening presentation delivered for Gold Coast Medicare Local

Learning objectives:

  • Understanding the Importance of early detection and management of people with COPD
  • Undertake a COPD Risk Assessment
  • Build Confidence in using A COPD Screening Device
  • Plan and implement a risk assessment and screening service

Instruction Sheets

Instruction sheet PiKo-6 and COPD 6 (170 KB) Instructions for using Guildcare COPD screening module (306 KB)

Case studies

Piggotts Pharmacy Story (1 MB)

 

This video is used with permission of The Pharmacy Guild of Australia.

For further information on COPD Screening Devices contact Lung Foundation Australia on 1800 654 301.

Case Study: Advantage Pharmacy Group
Advantage Pharmacy Case Study 300pxOn 19 November, 2014 the Advantage Bairnsdale Pharmacy conducted a COPD screening for World COPD Day. In the lead up to this event the pharmacy accessed a range of resources and training through Lung Foundation Australia including promotional resources, a PiKo-6 (COPD screening device) and online training for staff. Read more.

Case Study: Horsham Amcal Pharmacy
Lyn Lockett Amacal Pharmacy photoLynn Lockett and her team at the Amcal Pharmacy in Horsham were part of a COPD pharmacy service trial in 2014 run by the Grampians Medicare Local and Lung Foundation Australia. The trial was so successful Lynn decided to continue the service for her customers. Read Lynn’s story for great tips on how to make a difference in your community with a COPD pharmacy service.

Read More
Case Study: Capital Chemist Charnwood
Samantha Kourtis
Samantha Kourtis is a Managing Partner at Capital Chemist Charnwood in the Canberra suburb of Charnwood. Her pharmacy won the Quality Care Pharmacy Program (QCPP), Pharmacy of the Year award in 2014. The same year Samantha won the Telstra Business Women’s Award.

Read More

 

 

Sponsors

The COPD National Program receives unrestricted sponsorship towards the development of training and resources from the following companies:

Foundation Partners:
Principal Partners:

Novartis Pharmaceuticals

AZ Logo 150px
Supporting Partners: GlaxoSmithKline.